The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis
Open accessAbstract
The widespread increase in life expectancy is accompanied by an increased prevalence of features of physical frailty. Signs and symptoms may include sarcopenia and osteopenia, reduced exercise capacity, and diminished sense of well-being. The pathogenesis of age-associated sarcopenia and osteopenia is multifactorial, and hormonal decline may be a contributing factor. Aging is associated with a progressive decrease in GH secretion, and more than 30% of elderly people have circulating IGF1 levels below the normal range found in the young. GH acts directly on target tissues, including skeletal muscle and bone among many others, but many effects are mediated indirectly by circulating (liver-derived) or locally produced IGF1. Aging is also associated with reduced insulin sensitivity which, in turn, may contribute to the impairment of IGF1 action. Recent experimental evidence suggests that besides the age-dependent decline in GH and IGF1 serum levels, the dysregulation of GH and IGF1 actions due to impairment of the post-receptor signaling machinery may contribute to the loss of muscle mass and osteopenia. This article will focus on the molecular mechanisms of impaired GH and IGF1 signaling and action in aging, and their role in the pathogenesis of sarcopenia and osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased adiposity and circulating concentrations of free fatty acids inhibit GH production and decrease plasma concentrations of IGF-1.”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [93]
In the citing paper
“This decrease in IGF-1 is associated with decreased muscle size and strength, decreased protein synthesis, and increased cell death,93 which in turn leads to increased visceral fat and decreased lean body mass.94”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [93]
In the citing paper
“GH acts both directly on bones and indirectly through liver-derived IGF-1 or locally produced IGF-1 [47].”
From Emerging role of liver-bone axis in osteoporosis (2024) · cites this paper as [47]
In the citing paper
“The growth hormone (GH)-IGF-1 axis is also involved in bone remodeling and metabolism and has an essential role in the achievement and maintenance of bone mass throughout life.”
From Emerging role of liver-bone axis in osteoporosis (2024) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemical and Biophysical Research Communications
Rc, A. N., On Filamentous Bacteriophage, M., Hoffmann, S., & Willbold, D. (1960) · Nature · doi:10.1038/186124d0 · Cited by 6,690
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
The American journal of clinical nutrition
(1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)92305-h · Cited by 3,316
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Role of insulin-like growth factors in embryonic and postnatal growth
Baker, J., Liu, J.-P., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80085-6 · Cited by 2,463
Comfortable and maximum walking speed of adults aged 20—79 years: reference values and determinants
Bohannon, R. W. (1997) · Age and Ageing · doi:10.1093/ageing/26.1.15 · Cited by 2,346
Cellular and Molecular Life Sciences
(2013) · Cellular and Molecular Life Sciences · doi:10.1007/18.1420-9071 · Cited by 1,804
The p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Cited by
Sorted by citations
Muscle–Organ Crosstalk: The Emerging Roles of Myokines
Severinsen, M. C. K., & Pedersen, B. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa016 · Cited by 1,226
“Muscle-derived IGF-1 can act on local osteoblasts that express the IGF-1 receptor and thereby promote bone formation (171).”
BackgroundSkeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bodine, S. C., & Baehr, L. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2014 · Cited by 1,159
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102
The p53 network: cellular and systemic DNA damage responses in aging and Cancer
Reinhardt, H. C., & Schumacher, B. (2012) · Trends in Genetics · doi:10.1016/j.tig.2011.12.002 · Cited by 458
Dietary Advanced Glycation End Products and Aging
Luevano-Contreras, C., & Chapman-Novakofski, K. (2010) · Nutrients · doi:10.3390/nu2121247 · Cited by 396
Dzik, K. P., & Kaczor, J. J. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04104-x · Cited by 357
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 323
Gene Networks Driving Bovine Mammary Protein Synthesis during the Lactation cycle
Bionaz, M., & Loor, J. J. (2011) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s7003 · Cited by 305
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis
Locatelli, V., & Bianchi, V. E. (2014) · International Journal of Endocrinology · doi:10.1155/2014/235060 · Cited by 326
Frailty and Protein-Energy Wasting in Elderly Patients with End Stage Kidney Disease
Kim, J. C., Kalantar‐Zadeh, K., & Kopple, J. D. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010047 · Cited by 309
A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease
Marty, E., Liu, Y., Samuel, A. M., Or, O., & Lane, J. (2017) · Bone · doi:10.1016/j.bone.2017.09.008 · Cited by 310
Cesari, M., Fielding, R. A., Pahor, M., Goodpaster, B. H., Hellerstein, M. K., van Kan, G. A., Anker, S. D., Rutkove, S. B., Vrijbloed, J. W., Isaac, M., et al. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-012-0078-2 · Cited by 294
Myokines: The endocrine coupling of skeletal muscle and bone
Gomarasca, M., Banfi, G., & Lombardi, G. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.010 · Cited by 283
Yan Fang, G. O. N. G., Luo, S., Fan, P., Zhu, H., Li, Y., & Huang, W. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00677-x · Cited by 241
Sex Differences in Muscle Wasting
Anderson, L. J., Liu, H. M., & Garcia, J. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_9 · Cited by 226
Cachexia, Muscle Wasting, and Frailty in Cardiovascular Disease
Bielecka-Dabrowa, A. M., Ebner, N., dos Santos, M. R., Ishida, J., Hasenfuss, G. P., & von Haehling, S. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2011 · Cited by 184
Role of IGF-I signaling in muscle bone interactions
Bikle, D. D., Tahimic, C. G. T., Chang, W., Wang, Y., Philippou, Α., & Barton, E. R. (2015) · Bone · doi:10.1016/j.bone.2015.04.036 · Cited by 187
Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults
Tay, L. B. G., Ding, Y. Y., Leung, B. P. L., Ismail, N. H., Yeo, A., Yew, S., Tay, K. S., Tan, C. H., & Chong, M. S. (2015) · AGE · doi:10.1007/s11357-015-9860-3 · Cited by 183
Understanding the Physiological Links Between Physical Frailty and Cognitive Decline
Ma, L., & Chan, P. (2020) · Aging and Disease · doi:10.14336/ad.2019.0521 · Cited by 180
Muscle–bone interactions: basic and clinical aspects
Cianferotti, L., & Brandi, M. L. (2013) · Endocrine · doi:10.1007/s12020-013-0026-8 · Cited by 170
Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis
Bennett, J. L., Pratt, A. G., Dodds, R. M., Sayer, A. A., & Isaacs, J. D. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00921-9 · Cited by 174
Insulin-Like Growth Factor-1 Receptor Is Regulated by microRNA-133 during Skeletal Myogenesis
Huang, M., Xu, H. M., Xie, S., Zhou, H., & Qu, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029173 · Cited by 166
Rivas, D. A., Lessard, S. J., Rice, N. P., Lustgarten, M. S., So, K., Goodyear, L. J., Parnell, L. D., & Fielding, R. A. (2014) · The FASEB Journal · doi:10.1096/fj.14-254490 · Cited by 153
Nutritional influences on age-related skeletal muscle loss
Welch, A. A. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003698 · Cited by 140
Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention
Brioche, T., Pagano, A. F., Py, G., & Chopard, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.006 · Cited by 129
Strandberg, T. E., Pitkälä, K. H., & Tilvis, R. S. (2011) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.08.003 · Cited by 134
Frailty, Sarcopenia, and Hormones
Morley, J. E., & Malmstrom, T. K. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.006 · Cited by 128
Forum on bone and skeletal muscle interactions: Summary of the proceedings of an ASBMR workshop
Bonewald, L. F., Kiel, D. P., Clemens, T. L., Esser, K. A., ORWOLL, E. S., O’Keefe, R. J., & Fielding, R. A. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1980 · Cited by 119
Tan, Y., Liu, J., Deng, Y. L., Cao, H., Xu, D., Cu, F., Lei, Y.-Y., Magdalou, J., Wu, M., Chen, L., et al. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.09.007 · Cited by 122
Erlandson, K. M., Allshouse, A. A., Jankowski, C. M., MaWhinney, S., Kohrt, W. M., & Campbell, T. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318289bb7e · Cited by 122
Endocrine Crosstalk Between Muscle and Bone
Brotto, M. A. P., & Johnson, M. L. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0209-0 · Cited by 120
Arthur, S. T., & Cooley, I. D. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4262 · Cited by 131
Implications of exercise-induced adipo-myokines in bone metabolism
Lombardi, G., Sanchis‐Gomar, F., Perego, S., Sansoni, V., & Banfi, G. (2015) · Endocrine · doi:10.1007/s12020-015-0834-0 · Cited by 124
Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions
Kelly, R. R., McDonald, L. T., Jensen, N. R., Sidles, S. J., & LaRue, A. C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00200 · Cited by 125
Lucassen, E. A., de Mutsert, R., le Cessie, S., Appelman‐Dijkstra, N. M., Rosendaal, F. R., van Heemst, D., den Heijer, M., Biermasz, N. R., & for the NEO study group (2017) · PLoS ONE · doi:10.1371/journal.pone.0176685 · Cited by 117
RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II
Hemingway, F., Taylor, R., Knowles, H. J., & Athanasou, N. A. (2010) · Bone · doi:10.1016/j.bone.2010.12.023 · Cited by 112
Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone?
Girgis, C. M., Mokbel, N., & DiGirolamo, D. J. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0204-5 · Cited by 110
Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis
Miyakoshi, N., Hongo, M., Mizutani, Y., & Shimada, Y. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0443-z · Cited by 111
Treiber, N., Maity, P., Singh, K., Kohn, M., Keist, A. F., Ferchiu, F., Sante, L., Frese, S., Bloch, W., Kreppel, F., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00658.x · Cited by 109
Skeletal disorders associated with the growth hormone–insulin-like growth factor 1 axis
Mazziotti, G., Lania, A. G., & CANALIS, E. M. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00649-8 · Cited by 112
Organ-organ communication: The liver's perspective
Wang, F., So, K., Xiao, J., & Wang, H. (2021) · Theranostics · doi:10.7150/thno.55795 · Cited by 107
Tezze, C., Sandri, M., & Tessari, P. (2023) · Nutrients · doi:10.3390/nu15184073 · Cited by 114
Huang, J. M., Hsu, Y., Mo, C., de Abreu, E. L., Kiel, D. P., Bonewald, L. F., Brotto, M., & Karasik, D. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2200 · Cited by 99
Mediators and Patterns of Muscle Loss in Chronic Systemic Inflammation
Pérez-Baos, S., Prieto‐Potín, I., Roman‐Blas, J. A., Sánchez‐Pernaute, O., Largo, R., & Herrero‐Beaumont, G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00409 · Cited by 101
Musculoskeletal Frailty: A Geriatric Syndrome at the Core of Fracture Occurrence in Older Age
Gielen, E., Verschueren, S., O’Neill, T. W., Pye, S. R., O’Connell, M. D. L., Lee, D. M., Ravindrarajah, R., Claessens, F., Laurent, M. R., Milisen, K., et al. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9622-5 · Cited by 101
Zhu, K., Meng, X., Kerr, D. A., Devine, A., Solah, V. A., Binns, C. W., & Prince, R. L. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.429 · Cited by 97
Prediction of sarcopenia using a combination of multiple serum biomarkers
Kwak, J. Y., Hwang, H., Kim, S., Choi, J. Y., Lee, S.-M., Bang, H., Kwon, E., Lee, K., Chung, S. G., & Kwon, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-26617-9 · Cited by 97
Guo, B., Zhang, Z.-K., Liang, C., Li, J., Liu, J., Lu, A., Zhang, B.-T., & Zhang, G. (2017) · Calcified Tissue International · doi:10.1007/s00223-016-0209-4 · Cited by 96
Exosomes and Extracellular RNA in Muscle and Bone Aging and Crosstalk
Qin, W., & Dallas, S. L. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00537-7 · Cited by 99
Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia
Hall, D. T., Ma, J. F., Marco, S. D., & Gallouzi, I. (2011) · Aging · doi:10.18632/aging.100358 · Cited by 98
Insulin-like growth factor-I (IGF-I) and clinical nutrition
Livingstone, C. (2013) · Clinical Science · doi:10.1042/cs20120663 · Cited by 94
Muscle Wasting Diseases: Novel Targets and Treatments
Furrer, R., & Handschin, C. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021041 · Cited by 94
Effects of Neurological Disorders on Bone Health
Kelly, R. R., Sidles, S. J., & LaRue, A. C. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.612366 · Cited by 92
Osteoporosis and sarcopenia: the connections
Tarantino, U., Baldi, J., Celi, M., Rao, C., Liuni, F. M., Iundusi, R., & Gasbarra, E. (2013) · Aging Clinical and Experimental Research · doi:10.1007/s40520-013-0097-7 · Cited by 85
Willett, N. J., Li, M.-T. A., Uhrig, B. A., Boerckel, J. D., Huebsch, N., Lundgren, T. S., Warren, G. L., & Guldberg, R. E. (2012) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0290 · Cited by 85
Insulin-Like Growth Factor Physiology
Holly, J. M. P., & Perks, C. M. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.009 · Cited by 83
Frailty biomarkers under the perspective of geroscience: A narrative review
Gonçalves, R. S. D. S. A., Maciel, Á. C. C., Rolland, Y., Vellas, B. J., & Barreto, P. D. S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101737 · Cited by 89
Muscle-Bone Crosstalk in the Masticatory System: From Biomechanical to Molecular Interactions
Buvinic, S., Balanta‐Melo, J., Kupczik, K., Vásquez, W., Beato, C., & Toro‐Ibacache, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.606947 · Cited by 82
Ma, L., Sha, G., Zhang, Y., & Li, Y. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s180934 · Cited by 78
Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis
Terracciano, C., Celi, M., Lecce, D., Baldi, J., Rastelli, E., Lena, E., Massa, R., & Tarantino, U. (2013) · Osteoporosis International · doi:10.1007/s00198-012-1990-1 · Cited by 75
Extrinsic Mechanisms Involved in Age-Related Defective Bone Formation
Marie, P. J., & Kassem, M. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2113 · Cited by 78
Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies
Adil, M., Khan, R. A., Kalam, A., Venkata, S. K., Kandhare, A. D., Ghosh, P., & Sharma, M. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.05.008 · Cited by 74
Baker, J. F., Davis, M., Alexander, R., Zemel, B. S., Mostoufi‐Moab, S., Justine Shults, A., Sulik, M. J., Schiferl, D. J., & Leonard, M. B. (2012) · Bone · doi:10.1016/j.bone.2012.11.035 · Cited by 71
Aging and lineage allocation changes of bone marrow skeletal (stromal) stem cells
Nehlin, J. O., Jafari, A., Tencerová, M., & Kassem, M. S. (2019) · Bone · doi:10.1016/j.bone.2019.03.041 · Cited by 68
Increased Muscle Force Production and Bone Mineral Density in ActRIIB-Fc-Treated Mature Rodents
Chiu, C.-S., Peekhaus, N., Weber, H., Adamski, S., Murray, E. M., Zhang, H. Z., Zhao, J. Z., Ernst, R., Lineberger, J., Huang, L., et al. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt030 · Cited by 68
Crosstalk Between the Neuroendocrine System and Bone Homeostasis
Zhao, Y., Peng, X., Wang, Q., Zhang, Z., Wang, L., Xu, Y., Yang, H., Bai, J., & Geng, D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad025 · Cited by 75
Obesity, body composition, and prostate cancer
Fowke, J. H., Motley, S. S., Concepcion, R. S., Penson, D. F., & Barocas, D. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-23 · Cited by 63
The multi-faceted nature of age-associated osteoporosis
Smit, A. E., Meijer, O. C., & Winter, E. M. (2024) · Bone Reports · doi:10.1016/j.bonr.2024.101750 · Cited by 78
Higher free thyroxine levels are associated with frailty in older men: the Health In Men Study
Yeap, B. B., Alfonso, H. S., Chubb, S. A. P., Walsh, J. P., Hankey, G. J., Almeida, O. P., & Flicker, L. A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04290.x · Cited by 61
Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
Filip, R., Radzki, R., & Bieńko, M. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s170533 · Cited by 60
Guo, W., Wong, S., Li, M., Liang, W., Liesa, M., Serra, C., Jasuja, R., Bartke, A., Kirkland, J. L., Shirihai, O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051180 · Cited by 59
Dufresne, S. S., Boulanger-Piette, A., Bossé, S., Argaw, A., Hamoudi, D., Marcadet, L., Gamu, D., Fajardo, V. A., Yagita, H., Penninger, J. M., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0533-1 · Cited by 59
Ricker, E. A., & Souza, M. J. D. (2016) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2016.09.001 · Cited by 58
de Magalhães, J. P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.950151 · Cited by 56
Circulating levels of IGF1 are associated with muscle strength in middle-aged- and oldest-old women
Taekema, D. G., Ling, C. H. Y., Blauw, G. J., Meskers, C. G. M., Westendorp, R. G. J., de Craen, A. J. M., & Maier, A. B. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0703 · Cited by 56
Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects
Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Lenzi, A., & Donini, L. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145811 · Cited by 56
Negaresh, R., Ranjbar, R., Baker, J., Habibi, A., Mokhtarzade, M., Gharibvand, M., & Fokin, A. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_310_17 · Cited by 56
Yan Fang, G. O. N. G., LUO, S. H., Fan, P., Jin, S., Zhu, H., Deng, T., Quan, Y., & Huang, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-75107-4 · Cited by 55
Bonjour, J., Kohrt, W. M., Levasseur, R., Warren, M. P., Whiting, S. J., & KRAENZLIN, M. E. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000183 · Cited by 57
Yeap, B. B., Paul Chubb, S. A., Lopez, D., Ho, K. K. Y., Hankey, G. J., & Flicker, L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12052 · Cited by 53
Lovell, D. I., Cuneo, R. C., Wallace, J. D., & McLellan, C. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.022 · Cited by 52
Chen, L., Zou, X., Zhang, R., Pi, C.-J., Wu, N., Yin, L., & Deng, Z. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.2.228 · Cited by 53
MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review
Dowling, L., Duseja, A., Vilaça, T., Walsh, J., & Goljanek‐Whysall, K. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12878 · Cited by 52
Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta‐analysis
Zhang, Z., Cao, Y., Tao, Y., Meng, E., Tang, J., Liu, Y., & Li, F. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107990 · Cited by 50
Sarcopenia is Related to Increased Risk for Low Bone Mineral Density
Wu, C.-H., Yang, K., Chang, H., Yen, J.-F., Tsai, K.-S., & Huang, K. (2012) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2012.07.010 · Cited by 49
Mou, K., Chan, S. M. H., & Vlahos, R. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108635 · Cited by 53
31st G. Heiner Sell Lectureship: Secondary Medical Consequences of Spinal Cord Injury
Bauman, W. A., Korsten, M. A., Radulovic, M., Schilero, G. J., Wech, J., & Spungen, A. M. (2012) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1804-354 · Cited by 47
Poggiogalle, E., Donini, L. M., Lenzi, A., Chiesa, C., & Pacifico, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i10.1747 · Cited by 47
Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
Carneros, D., López‐Lluch, G., & Bustos, M. (2020) · Nutrients · doi:10.3390/nu12113472 · Cited by 48
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Al‐Shanti, N., & Stewart, C. E. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23420 · Cited by 47
Growth Hormone-Insulin-Like Growth Factor Axis, Thyroid Axis, Prolactin, and Exercise
Hackney, A. C., Davis-Wilson, H. C., & Lane, A. R. (2016) · Frontiers of hormone research · doi:10.1159/000445147 · Cited by 46
Deng, Y., Cao, H., Cu, F., Xu, D., Lei, Y.-Y., Tan, Y., Magdalou, J., Wang, H., & Chen, L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.02.008 · Cited by 45
Haisa, M. (2013) · Journal of International Medical Research · doi:10.1177/0300060513476585 · Cited by 45
Suman, S., Kallakury, B., Fornace, A. J., & Datta, K. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10684 · Cited by 45
Frost, R. A., & Lang, C. H. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.012 · Cited by 47
Lee, A., McArthur, C., Ioannidis, G., Duque, G., Adachi, J. D., Griffith, L. E., Thabane, L., & Παπαϊωάννου, Α. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.09.027 · Cited by 46
Vallejo, A. N., Mueller, R. G., Hamel, D. L., Way, A., Dvergsten, J., Griffin, P. C., & Newman, A. B. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.09.006 · Cited by 47
Zamboni, M. M., Mazzali, G., Brunelli, A., Saatchi, T., Urbani, S., Giani, A., Rossi, A. P., Zoico, E., & Fantin, F. (2022) · Cells · doi:10.3390/cells11213361 · Cited by 47
Integrated Therapies for Osteoporosis and Sarcopenia: From Signaling Pathways to Clinical Trials
Girgis, C. M. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-9956-x · Cited by 43
Metadata
- Authors
- Perrini, S., Laviola, L., Carreira, M. C., Cignarelli, A., Natalicchio, A., & Giorgino, F.
- Affiliations
- University of Bari Aldo Moro (IT)
- ORCID
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2010-03-02
- Volume
- 205
- Issue
- 3
- Pages
- 201-210
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2132915404
- Cited by
- 317
- References
- 112
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 13 · 2023: 12 · 2022: 17 · 2021: 18 · 2020: 14 · 2019: 15 · 2018: 23 · 2017: 17 · 2016: 25 · 2015: 23 · 2014: 29 · 2013: 27 · 2012: 36
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- growth hormone, insulin-like growth factor I, somatotropic axis, sarcopenia, osteoporosis, osteopenia, aging, muscle atrophy, bone loss, insulin resistance, post-receptor signaling, frailty, skeletal muscle, bone
- MeSH terms
- Animals, Bone and Bones, Disease Models, Animal, Humans, Insulin-Like Growth Factor I, Osteoporosis, Growth Hormone, Signal Transduction, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review